SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Strauss David P

(Last)

(First)

(Middle)

C/O LINDE PLC

FORGE, 43 CHURCH STREET WEST

(Street)

WOKING SURREY

GU216HT

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
LINDE PLC [ LIN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Executive VP, Chief HR Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/16/2024

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	12/16/2024		S		2,218	D	$434.35	25,926.097	D
Ordinary Shares								1,909.032	I	401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Options (right to buy)	$270.99							03/07/2023⁽¹⁾	03/07/2032	Ordinary Shares	10,200		10,200	D
Stock Options (right to buy)	$253.68							03/08/2022⁽²⁾	03/08/2031	Ordinary Shares	15,925		15,925	D
Stock Options (right to buy)	$354.14							03/07/2024⁽³⁾	03/07/2033	Ordinary Shares	8,515		8,515	D
Restricted Stock Units	⁽⁴⁾							⁽⁴⁾	⁽⁴⁾	Ordinary Shares	1,290		1,290	D
Stock Options (right to buy)	$173.13							⁽⁵⁾	03/09/2030	Ordinary Shares	20,870		20,870	D
Stock Options (right to buy)	$176.63							03/20/2020⁽⁶⁾	03/20/2029	Ordinary Shares	20,985		20,985	D
Restricted Stock Units	⁽⁷⁾							⁽⁷⁾	⁽⁸⁾	Ordinary Shares	1,180		1,180	D
Restricted Stock Units	⁽⁹⁾							⁽⁹⁾	⁽⁹⁾	Ordinary Shares	1,235		1,235	D
Stock Options (right to buy)	$154							⁽¹⁰⁾	02/27/2028	Ordinary Shares	15,090		15,090	D
Deferred Stock Units	⁽¹¹⁾							⁽¹²⁾	⁽¹²⁾	Ordinary Shares	236.828		236.828	D
Stock Options (right to buy)	$465.29							03/07/2025⁽¹³⁾	03/07/2034	Ordinary Shares	8,010		8,010	D

Explanation of Responses:

1. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.

2. This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.

3. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.

4. Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.

5. This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.

6. This option vests over three years in three consecutive equal annual installments beginning on March 20, 2020.

7. Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis.

8. Restricted Stock Units that will vest in full and payout on or about March 8, 2024 in Linde plc Ordinary Shares on a one-for-one basis.

9. Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.

10. This option vested in full three years after the grant date.

11. Conversion to Linde plc Ordinary Shares is on a one-to-one basis.

12. Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan.

13. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.

Remarks:

	Anthony M. Pepper as attorney-in-fact	12/17/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.